TAP
53
2
BIIB
25
-10
DAL
64
6
GM
57
2
MAR
47
2
CB
58
-2
BF.B
50
-3
FE
50
-7
TROW
34
2
YUM
40
-5
ZION
52
2
NWS
41
4
AMG
41
3
ETR
71
2
FAST
48
2
JPM
55
2
FDX
51
4
WFC
58
3
ROK
48
2
LB
52
7
TAP
53
2
BIIB
25
-10
DAL
64
6
GM
57
2
MAR
47
2
CB
58
-2
BF.B
50
-3
FE
50
-7
TROW
34
2
YUM
40
-5
ZION
52
2
NWS
41
4
AMG
41
3
ETR
71
2
FAST
48
2
JPM
55
2
FDX
51
4
WFC
58
3
ROK
48
2
LB
52
7
Financhill
Back

Bio-Path Holdings Vs. Actinium Pharmaceuticals Industry Stock Comparison

Sell
30

BPTH
Bio-Path Holdings

Last Price:
1.00
Seasonality Move:
9.55%
Sell
24

ATNM
Actinium Pharmaceuticals

Last Price:
1.80
Seasonality Move:
4.44%
Sell
30
Bio-Path Holdings (BPTH) is a Sell

Is Bio-Path Holdings a Buy, Sell or Hold?

  • The current Bio-Path Holdings [BPTH] share price is $1.05. The Score for BPTH is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • BPTH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
24
Actinium Pharmaceuticals (ATNM) is a Sell

Is Actinium Pharmaceuticals a Buy, Sell or Hold?

  • The current Actinium Pharmaceuticals [ATNM] share price is $1.82. The Score for ATNM is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • ATNM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BPTH Stock Price Chart

What is Bio-Path Holdings's stock price today?

  • The Bio-Path Holdings share price today is $1.05
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPTH is experiencing buying pressure, which is a positive indicator for future bullish movement.

ATNM Stock Price Chart

What is Actinium Pharmaceuticals's stock price today?

  • The Actinium Pharmaceuticals share price today is $1.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATNM is experiencing slight buying pressure.

BPTH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 40.31 Sell
Chaikin Money Flow: 48035 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.93 - 1.37) Sell
Bollinger Bands (100): (1.29 - 2.47) Sell

ATNM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 30.88 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.82 - 2.04) Sell
Bollinger Bands (100): (3.26 - 8.88) Sell

BPTH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.99 Buy
20-day SMA: 1.07 Sell
50-day SMA: 1.41 Sell
200-day SMA: 4.62 Sell
8-day EMA: 1.01 Buy
20-day EMA: 1.09 Sell
50-day EMA: 1.43 Sell
200-day EMA: 5.59 Sell

ATNM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.86 Sell
20-day SMA: 1.92 Sell
50-day SMA: 4.02 Sell
200-day SMA: 6.27 Sell
8-day EMA: 1.85 Sell
20-day EMA: 2.14 Sell
50-day EMA: 3.56 Sell
200-day EMA: 5.9 Sell

Bio-Path Holdings Earnings Growth & BPTH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $5.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $27.20 per share, and an increase next year of $2.16 per share.

Actinium Pharmaceuticals Earnings Growth & ATNM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.09 per share, an increase this year of $0.62 per share, and an increase next year of $0.66 per share.

Bio-Path Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Actinium Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):